A Novel Orally Bioavailable Small Molecule Dual Src/Tubulin Inhibitor That Provides Long Term Survival In a Murine Model of Glioblastoma

Ciesielski MJ, Bu Y, Munich SA, Teegarden P, Smolinski MP, Clements JL, Lau JYN, Hangauer DG, Fenstermaker RA: KX2-361: A Novel Orally Bioavailable Small Molecule Dual Src/Tubulin Inhibitor That Provides Long Term Survival In a Murine Model of Glioblastoma. J Neurooncol (epub September 20, 2018 DOI 10.1007/s11060-018-2992-4). PMID 30238350

Please notify our office immediately if you have a fever, cough, runny nose, or shortness of breath or have been in contact with someone who has been diagnosed with COVID-19. UBNS is following all CDC and New York State Dept. of Health guidelines for preventing the spread of COVID-19.